NCT01383096 - Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Healthy Volunteers

Interventions

DRUG

OZ439 mesylate 800mg Powder in Bottle for Oral Suspension

OZ439 800 mg (as free base) as powder in a bottle for reconstitution in a suspension prior to oral administration

DRUG

OZ439 mesylate 400mg Prototype Solution Formula 1

OZ439 400 mg (as free base) as a prototype solution formulation 1

DRUG

OZ439 mesylate 800mg Prototype Solution Formula 1

OZ439 800 mg (as free base) as a prototype solution formulation 1

DRUG

OZ439 mesylate 800mg Prototype Solution Formula 2

OZ439 800 mg (as free base) as a prototype solution formulation 2

Trial Locations (1)

AMREP Centre for Clinical Studies, Melbourne